POWAY, Calif., Oct. 1 /PRNewswire/ -- Vet-Stem, Inc. announced that Dr. Robert Harman, DVM, MPVM, CEO of Vet-Stem, will present a talk entitled "Stem Cell Therapy: Mechanisms of Action" at the Annual Research Symposium of the American College of Veterinary Surgeons (ACVS) in Seattle, WA, October 21, 2010.
Dr. Harman has presented at more than 40 veterinary and human stem cell conferences since the founding of Vet-Stem in 2002. The ACVS is the largest veterinary surgical meeting in the world, with over 7,000 attendees from around the globe. This seminar talk will provide continuing education for veterinarians on the most current research about how stem cells work to provide healing and improvement in quality of life of animals.
As the founder and scientific director of Vet-Stem, Dr. Harman has been at the forefront of development of the practical applications of stem cells in our animal populations and has consulted with a number of human stem cell companies to share these veterinary findings for the benefit of potential therapy for people.
Vet-Stem's clinical team has rapidly developed this market, training over 4,000 veterinarians in the United States alone and providing stem cells for treatment of over 7,000 horses and dogs. Peer-reviewed publications in the journals Veterinary Therapeutics and the American Journal of Veterinary Research have demonstrated the effectiveness of these types of treatments in horses and dogs. In addition, Dr. Harman has co-authored two publications on how these stem cells from fat tissue can help treat multiple sclerosis and autoimmune diseases in people.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. This privately held company delivers stem cell and related services and products to veterinarians to treat diseases in dogs, cats and horses. These technologies utilize the natural healing properties inherent in all animals to reduce pain and improve the quality of life of our pets.
In January of 2004, Vet-Stem introduced the first veterinary stem cell service in the United States. Since that time there has been rapid adoption of this technology for treatment of tendon, ligament, and joint injuries by the veterinary community. Published studies have confirmed that these stem cells can dramatically improve the healing of injuries and diseases that have had very few treatment options in the past.
Chief Operating Officer, VP Sales & Marketing
Ph: 858-748-2004 ext 102
SOURCE Vet-Stem, Inc.